| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |